Infectious Diseases (all articles)
COVID 5 times deadlier than flu for hospital patients, study finds
18 Dec, 2020 | 09:53h | UTCCOVID 5 times deadlier than flu for hospital patients, study finds – CIDRAP
Commentary on Twitter
Among people admitted to hospital, #COVID19 was associated with increased risk of various extrapulmonary clinical manifestations, compared with seasonal influenza #BMJResearch https://t.co/R0J9HCvsH2
— The BMJ (@bmj_latest) December 16, 2020
Studies reveal deadliness of COVID-19, even in young adults
18 Dec, 2020 | 09:57h | UTCData reveal deadliness of COVID-19, even in young adults – CIDRAP
Studies warn of COVID vaccine access issues for low-income nations
18 Dec, 2020 | 09:54h | UTCStudies warn of COVID vaccine access issues for low-income nations – CIDRAP
Study 1: Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis – The BMJ
Editorial: Equitable global access to coronavirus disease 2019 vaccines – The BMJ
Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action
18 Dec, 2020 | 09:52h | UTCCommentaries: Pregnant women excluded from three-quarters of COVID-19 treatment trials – The Lancet AND Expert reaction to opinion piece on pregnant women and COVID-19 treatment trials – Science Media Centre
Commentary on Twitter (thread – click for more)
NEW—Pregnant women are among those most in need of safe and effective therapies against #COVID19, but are routinely excluded from 3/4 of treatment trials. Read the review published in @LancetGH: https://t.co/xvBfHqnHMe @WHO pic.twitter.com/pBuTcsUZ0O
— The Lancet (@TheLancet) December 17, 2020
Survey: Around 1 in 5 COVID-19 patients exhibit symptoms for a period of 5 weeks or longer; Around 1 in 10 COVID-19 patients exhibit symptoms for a period of 12 weeks or longer
18 Dec, 2020 | 09:49h | UTCThe prevalence of long COVID symptoms and COVID-19 complications – Office of National Statistics
Commentary on Twitter
The prevalence of long COVID symptoms & COVID-19 complications published by @ONS
10% of covid positive patients exhibit symptoms for a period of > 12 weeks
20% for > 5 weeksGreat work by @DanAyoubkhani @Vnafilyan https://t.co/8YgxkCG847
@martinmckee pic.twitter.com/Itizxkk8xC
— Prof Kamlesh Khunti (@kamleshkhunti) December 17, 2020
Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicenter collaborative study
18 Dec, 2020 | 09:50h | UTCCommentary: Study highlights neurological impact of COVID-19 on children – University of Manchester
Commentary on Twitter (thread – click for more)
New #COVID19 Research: An international call for cases identified 38 children with neurological disease related to #SARSCoV2 infection
Recurring patterns of disease were identified, with #neuroimaging abnormalities ranging from mild to severehttps://t.co/a3bjPlOY0z pic.twitter.com/W0lxLP4aAh
— The Lancet Child & Adolescent Health (@LancetChildAdol) December 16, 2020
CDC Guidelines for Gonococcal Infection, 2020. CDC recommends a single 500 mg intramuscular dose of ceftriaxone for uncomplicated gonorrhea, with oral doxycycline for 7 days when chlamydial coinfection has not been excluded
18 Dec, 2020 | 09:40h | UTCCommentary: CDC Guidelines Recommend Ceftriaxone Monotherapy for Uncomplicated Gonorrhea – NEJM Journal Watch
Commentary on Twitter
https://twitter.com/GarrettHile/status/1339732944613720064
Scientists fear that ‘covidization’ is distorting research: Some researchers worry that shifting priorities towards pandemic-focused science comes at the expense of other disciplines.
17 Dec, 2020 | 08:47h | UTCScientists fear that ‘covidization’ is distorting research – Nature
COVID-19 is 10 times deadlier for people with Down syndrome, raising calls for early vaccination
17 Dec, 2020 | 08:51h | UTC
How a torrent of COVID science changed research publishing — in seven charts
17 Dec, 2020 | 08:48h | UTCHow a torrent of COVID science changed research publishing — in seven charts – Nature
2021: research and medical trends in a post-pandemic world
17 Dec, 2020 | 08:46h | UTC2021: research and medical trends in a post-pandemic world – Nature
Systematic review: Infection and mortality of healthcare workers worldwide from COVID-19
17 Dec, 2020 | 08:40h | UTC
Commentary on Twitter
https://twitter.com/DrSoumyadeepB/status/1335124725576552448
Study: Filtration efficiency of face masks used by the public during the COVID-19 pandemic are, in many cases, nearly equivalent to or better than their non-N95 respirator medical mask counterparts
17 Dec, 2020 | 08:43h | UTCEditorial: Filtration Efficiency of Face Masks Used by the Public During the COVID-19 Pandemic
Commentary on Twitter
Marked reassurance on the value of cloth masks.
A new @JAMAInternalMed assessment today https://t.co/bTrurKeG71 Attention to fit is key, such as aluminum nose bridge, ties, no beard, etc 😷😷 @Phillip_Clapp @UNC_SOM pic.twitter.com/ZCMTT2OWXc— Eric Topol (@EricTopol) December 11, 2020
Individual and community-level risk predictor for COVID-19 mortality in the US, with risk calculator
16 Dec, 2020 | 09:42h | UTCIndividual and community-level risk for COVID-19 mortality in the United States – Nature Medicine
Calculator: Covid-19 risk
Commentary on Twitter
New @NatureMedicine
What is your individualized risk of dying from covid19?https://t.co/Bg61t3raVNhttps://t.co/tQGH0ilsmR (1.1X for me) pic.twitter.com/9pkwyCUAVw— Eric Topol (@EricTopol) December 11, 2020
COVID-19 mimics on chest CT: a pictorial review and radiologic guide
17 Dec, 2020 | 08:37h | UTC
Video (5min): Ivermectin for COVID-19 | A Doctor Explains
16 Dec, 2020 | 09:43h | UTCIvermectin For COVID-19 | A Doctor Explains – ZDoggMD
Nature’s 10: ten people who helped shape science in 2020
16 Dec, 2020 | 09:52h | UTCNature’s 10: ten people who helped shape science in 2020 – Nature
ACR Guidance for pediatric patients with multisystem inflammatory syndrome in children associated with SARS‐CoV‐2
16 Dec, 2020 | 09:32h | UTC
Report: Lung transplantation for 3 patients with severe COVID-19
16 Dec, 2020 | 09:34h | UTCLung transplantation for patients with severe COVID-19 – Science Translational Medicine
Commentaries: COVID-19 can damage lungs so badly that ‘only hope’ is transplant – MedicalXpress
Commentary on Twitter
Case reports from 3 patients with severe #COVID19 who received lung transplants show the disease can cause extensive lung damage similar to that seen in pulmonary #fibrosis, and hints transplantation may be a viable treatment. @NUFeinbergMed @ScienceTM https://t.co/wXi0tx8gFg pic.twitter.com/vyerJLlJxi
— Science Magazine (@ScienceMagazine) November 30, 2020
Consensus Guideline: Defining and managing COVID-19-associated pulmonary aspergillosis
15 Dec, 2020 | 01:42h | UTC
Perspective: How Science Beat the Virus – And what it lost in the process
15 Dec, 2020 | 01:40h | UTCHow Science Beat the Virus – The Atlantic
Commentary from the author on Twitter (thread – click for more)
🚨I wrote the Atlantic’s next cover story on the COVIDization of science. No other disease has been scrutinized so intensely, by so much combined intellect, in so brief a time. This piece is about both the victories achieved & the weaknesses exposed. 1/ https://t.co/RbL9mVHhEv
— Ed Yong is not here (@edyong209) December 14, 2020
The coronavirus at 1: A year into the pandemic, what scientists know about how it spreads, infects, and sickens
15 Dec, 2020 | 01:42h | UTC
News Release: The Sputnik V vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials
15 Dec, 2020 | 01:36h | UTC
[Preprint] RECOVERY trial: Azithromycin does not improve outcomes in hospitalized patients with COVID-19
15 Dec, 2020 | 01:44h | UTCNews release: RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19
Commentary on Twitter
New RECOVERY result. In patients hospitalised with COVID-19, azithromycin did not provide any clinical benefit. 28 day mortality (19% vs 19%) (rate ratio 1·00; 95% confidence interval [CI] 0·90-1·12; p=0·99). No effect on secondary outcomes either.https://t.co/PTklz40WKr pic.twitter.com/NCzvRIND0S
— Peter Horby @peterhorby.bsky.social (@PeterHorby) December 14, 2020
Arab nations first to approve Chinese COVID vaccine — despite lack of public data
15 Dec, 2020 | 01:38h | UTCArab nations first to approve Chinese COVID vaccine — despite lack of public data – Nature